PF-06372865 in Subjects With Photosensitive Epilepsy

A Double Blind, Randomized, Cross- Over Study Examining Efficacy Of Pf-06372865 In A Photosensitivity Epilepsy Study Using Lorazepam As A Positive Control

PF-06372865 in subjects with photosensitive epilepsy

Inclusion Criteria:

• A diagnosis and history of photoparoxysmal response on electroencephalogram (EEG) with or without a diagnosis of epilepsy for which subjects are taking up to 0 - 2 concomitant antiepileptic drugs.
• Subjects currently taking antiepileptic drug(s) to be on a stable dose for 4 weeks prior to Screening Visit.
• A minimum average standardized photosensitive range (SPR) across all screening timepoints of 4 in the most sensitive eye condition and a non-zero average in at least one other eye condition.

Exclusion Criteria:

• Subjects with a history of status epilepticus.
• Subjects who have experienced a generalized tonic-clonic convulsion in the past 6 months, at the time of the initial screening visit.